Hypha Life Sciences
Contract research for pharmaceutical and agricultural biotechnology.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| Total Funding | 000k | ||
Hypha Life Sciences operates as a contract research organization (CRO) created by BioGenerator, focusing on providing research and development services to the biopharma, agricultural, and biotechnology sectors. The company specializes in offering access to capabilities in genetic engineering, metabolomics, and proteomics to improve nutritional quality. Based in St. Louis, Missouri, Hypha Life Sciences serves as a research services company for biotechnology innovators.
The company was established by BioGenerator and its Executives in Residence (EIR) program. In 2021, BioGenerator made one of its largest investments in Hypha Life Sciences, which was among eight companies to receive first-time investments that year. The investment was part of a larger $3.3 million deployment by BioGenerator into 18 local bioscience companies.
Hypha Life Sciences' business model is centered on providing contract research services. This enables client companies in the pharmaceutical and agricultural industries to advance their R&D projects without needing to build out these specific capabilities in-house. The firm's services are designed to help innovators enhance their products, particularly in areas like nutritional quality. The company is privately held and received early-stage venture capital funding on January 1, 2021, from investors including BioGenerator Ventures.
Keywords: contract research organization, CRO, biotechnology services, genetic engineering, metabolomics, proteomics, agricultural biotechnology, pharmaceutical services, biopharma R&D, BioGenerator, life sciences research, nutritional quality, St. Louis startup
